EMBC INVESTOR ALERT: Embecta Corp. (EMBC) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit- HBSS

Embecta Corp. ( NASDAQ: EMBC ) investors are being alerted to a potential class action lawsuit concerning alleged violations of federal securities laws. The investigation follows a class action filing that claims Embecta misrepresented the commercial stability of its insulin pen needle business. The class period is Nov. 25, 2025 – May 4, 2026, with a lead plaintiff deadline of Aug. 17, 2026. The lawsuit alleges that Embecta repeatedly assured investors of the stability of its pen needle portfolio, while in reality, the company was experiencing significant competitive share loss and market volume softness, which management allegedly knew or disregarded. This alleged deception was revealed on May 5, 2026, when Embecta reported a substantial revenue decline, a 43% cut to its full-year adjusted EPS guidance, and a drastic 93% reduction in its quarterly dividend. The stock price fell 57.8% in a single trading day following this announcement. The investigation aims to determine if Embecta's assurances were misleading. Investors who purchased Embecta stock during the class period and suffered losses are encouraged to contact the legal team.